192 related items for PubMed ID: 7991711
1. [Selected issues of biological aspects of eating disorders].
Włodarczyk-Bisaga K, Bisaga A.
Psychiatr Pol; 1994; 28(5):579-91. PubMed ID: 7991711
[Abstract] [Full Text] [Related]
2. Endocrine dysfunction in anorexia nervosa and bulimia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors.
Hudson JI, Hudson MS.
Psychiatr Dev; 1984; 2(4):237-72. PubMed ID: 6098898
[Abstract] [Full Text] [Related]
3. The endocrinology of anorexia nervosa and bulimia nervosa.
Newman MM, Halmi KA.
Neurol Clin; 1988 Feb; 6(1):195-212. PubMed ID: 3288860
[Abstract] [Full Text] [Related]
4. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.
Kaye WH, Weltzin TE.
J Clin Psychiatry; 1991 Dec; 52 Suppl():41-8. PubMed ID: 1752859
[Abstract] [Full Text] [Related]
5. The endocrinology of anorexia nervosa and bulimia nervosa.
Newman MM, Halmi KA.
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):195-212. PubMed ID: 2897909
[Abstract] [Full Text] [Related]
6. The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: pathophysiologic implications.
Laue L, Gold PW, Richmond A, Chrousos GP.
Adv Pediatr; 1991 Mar; 38():287-316. PubMed ID: 1656715
[No Abstract] [Full Text] [Related]
7. [Role of the neurohypophysis in psychological stress].
Scantamburlo G, Ansseau M, Legros JJ.
Encephale; 2001 Mar; 27(3):245-59. PubMed ID: 11488255
[Abstract] [Full Text] [Related]
8. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux DL.
N Engl J Med; 1986 May 22; 314(21):1335-42. PubMed ID: 3010109
[Abstract] [Full Text] [Related]
9. Neurochemistry of bulimia nervosa.
Kaye WH, Weltzin TE.
J Clin Psychiatry; 1991 Oct 22; 52 Suppl():21-8. PubMed ID: 1682306
[Abstract] [Full Text] [Related]
10. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
Frank GK, Kaye WH, Ladenheim EE, McConaha C.
Appetite; 2001 Aug 22; 37(1):9-14. PubMed ID: 11562153
[Abstract] [Full Text] [Related]
11. Endogenous opioids and hypothalamic-pituitary-adrenal function in obesity and anorexia nervosa.
Cavagnini F, Invitti C, Dubini A, Danesi L, Silvestri G, Passamonti M, Magella A, Morabito F.
Adv Biochem Psychopharmacol; 1987 Aug 22; 43():273-81. PubMed ID: 3035891
[No Abstract] [Full Text] [Related]
12. Anorexia nervosa, obsessional behavior, and serotonin.
Kaye WH.
Psychopharmacol Bull; 1997 Aug 22; 33(3):335-44. PubMed ID: 9550876
[Abstract] [Full Text] [Related]
13. Research update on serotonin function in bulimia nervosa and anorexia nervosa.
Wolfe BE, Metzger E, Jimerson DC.
Psychopharmacol Bull; 1997 Aug 22; 33(3):345-54. PubMed ID: 9550877
[Abstract] [Full Text] [Related]
14. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
Kaye WH, Berrettini W, Gwirtsman H, George DT.
Arch Gen Psychiatry; 1990 Jun 22; 47(6):548-56. PubMed ID: 2350207
[Abstract] [Full Text] [Related]
15. The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia nervosa.
Baranowska B, Baranowska-Bik A, Bik W, Martynska L.
Neuro Endocrinol Lett; 2008 Feb 22; 29(1):37-40. PubMed ID: 18283238
[Abstract] [Full Text] [Related]
16. Eating disorders in females: genetics, pathophysiology, and treatment.
Halmi KA.
J Pediatr Endocrinol Metab; 2002 Dec 22; 15 Suppl 5():1379-86. PubMed ID: 12510994
[Abstract] [Full Text] [Related]
17. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.
Psychopharmacol Bull; 1989 Dec 22; 25(3):433-8. PubMed ID: 2533990
[Abstract] [Full Text] [Related]
18. The endocrinology of anorexia nervosa and bulimia nervosa.
Thomas MA, Rebar RW.
Curr Opin Obstet Gynecol; 1990 Dec 22; 2(6):831-6. PubMed ID: 2130987
[No Abstract] [Full Text] [Related]
19. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
Liu JP, Clarke IJ, Funder JW, Engler D.
J Clin Invest; 1994 Apr 22; 93(4):1439-50. PubMed ID: 8163648
[Abstract] [Full Text] [Related]
20. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia.
Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH.
Psychoneuroendocrinology; 1987 Apr 22; 12(2):131-40. PubMed ID: 3037583
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
